Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
December-2024 Volume 30 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
December-2024 Volume 30 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

SPOCK: Master regulator of malignant tumors (Review)

  • Authors:
    • Mingyuan Xiao
    • Jiancheng Xue
    • Enli Jin
  • View Affiliations / Copyright

    Affiliations: Department of Rehabilitation, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110134, P.R. China, Department of Otolaryngology, Head and Neck Surgery, The Second People's Hospital of Shenzhen, The First Affiliated Hospital of Shenzhen University, Shenzhen, Guangdong 518035, P.R. China
    Copyright: © Xiao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 231
    |
    Published online on: October 8, 2024
       https://doi.org/10.3892/mmr.2024.13355
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

SPARC/osteonectin, CWCV and Kazal‑like domain proteoglycan (SPOCK) is a family of highly conserved multidomain proteins. In total, three such family members, SPOCK1, SPOCK2 and SPOCK3, constitute the majority of extracellular matrix glycoproteins. The SPOCK gene family has been demonstrated to serve key roles in tumor regulation by affecting MMPs, which accelerates the progression of cancer epithelial‑mesenchymal transition. In addition, they can regulate the cell cycle via overexpression, inhibit tumor cell proliferation by inactivating PI3K/AKT signaling and have been associated with numerous microRNAs that influence the expression of downstream genes. Therefore, the SPOCK gene family are potential cancer‑regulating genes. The present review summarizes the molecular structure, tissue distribution and biological function of the SPOCK family of proteins, in addition to its association with cancer. Furthermore, the present review documents the progress made in investigations into the role of SPOCK, whilst also discussing prospects for the future of SPOCK‑targeted therapy, to provide novel ideas for clinical application and treatment.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

View References

1 

Carioli G, Malvezzi M, Bertuccio P, Boffetta P, Levi F, La Vecchia C and Negri E: European cancer mortality predictions for the year 2021 with focus on pancreatic and female lung cancer. Ann Oncol. 32:478–487. 2021. View Article : Google Scholar : PubMed/NCBI

2 

Dolgin E: Cancer's new normal. Nat Cancer. 2:1248–1250. 2021. View Article : Google Scholar : PubMed/NCBI

3 

Cheek DM and Naxerova K: Mapping the long road to cancer. Cell. 185:939–940. 2022. View Article : Google Scholar : PubMed/NCBI

4 

Siegel RL, Miller KD, Wagle NS and Jemal A: Cancer statistics, 2023. CA Cancer J Clin. 73:17–48. 2023. View Article : Google Scholar : PubMed/NCBI

5 

Bonnet F, Perin JP, Maillet P, Jolles P and Alliel PM: Characterization of a human seminal plasma glycosaminoglycan-bearing polypeptide. Biochem J. 288((Pt 2)): 565–569. 1992. View Article : Google Scholar : PubMed/NCBI

6 

Charbonnier F, Périn JP, Roussel G, Nussbaum JL and Alliel PM: Cloning of testican/SPOCK in man and mouse. Neuromuscular expression perspectives in pathology. C R Seances Soc Biol Fil. 191:127–133. 1997.(In French). PubMed/NCBI

7 

Hausser HJ, Decking R and Brenner RE: Testican-1, an inhibitor of pro-MMP-2 activation, is expressed in cartilage. Osteoarthritis Cartilage. 12:870–877. 2004. View Article : Google Scholar : PubMed/NCBI

8 

Perurena N, Zandueta C, Martinez-Canarias S, Moreno H, Vicent S, Almeida AS, Guruceaga E, Gomis RR, Santisteban M, Egeblad M, et al: EPCR promotes breast cancer progression by altering SPOCK1/testican 1-mediated 3D growth. J Hematol Oncol. 10:232017. View Article : Google Scholar : PubMed/NCBI

9 

Zhong J, Krawczyk SA, Chaerkady R, Huang H, Goel R, Bader JS, Wong GW, Corkey BE and Pandey A: Temporal profiling of the secretome during adipogenesis in humans. J Proteome Res. 9:5228–5238. 2010. View Article : Google Scholar : PubMed/NCBI

10 

Chiarini A, Onorati F, Marconi M, Pasquali A, Patuzzo C, Malashicheva A, Irtyega O, Faggian G, Pignatti PF, Trabetti E, et al: Studies on sporadic non-syndromic thoracic aortic aneurysms: II. Alterations of extra-cellular matrix components and focal adhesion proteins. Eur J Prev Cardiol. 25 (Suppl 1):S51–S58. 2018. View Article : Google Scholar

11 

Váncza L, Tátrai P, Reszegi A, Baghy K and Kovalszky I: SPOCK1 with unexpected function. The start of a new career. Am J Physiol Cell Physiol. 322:C688–c693. 2022. View Article : Google Scholar : PubMed/NCBI

12 

Gao Y, Yu M, Ma M, Zhuang Y, Qiu X, Zhao Q, Dai J, Cai H and Yan X: SPOCK1 contributes to the third-generation EGFR tyrosine kinase inhibitors resistance in lung cancer. J Cell Biochem. 120:12566–12573. 2019. View Article : Google Scholar : PubMed/NCBI

13 

Charbonnier F, Périn JP, Mattei MG, Camuzat A, Bonnet F, Gressin L and Alliel PM: Genomic organization of the human SPOCK gene and its chromosomal localization to 5q31. Genomics. 48:377–380. 1998. View Article : Google Scholar : PubMed/NCBI

14 

Alliel PM, Perin JP, Jolles P and Bonnet FJ: Testican, a multidomain testicular proteoglycan resembling modulators of cell social behaviour. Eur J Biochem. 214:347–350. 1993. View Article : Google Scholar : PubMed/NCBI

15 

Hohenester E, Maurer P, Hohenadl C, Timpl R, Jansonius JN and Engel J: Structure of a novel extracellular Ca(2+)-binding module in BM-40. Nat Struct Biol. 3:67–73. 1996. View Article : Google Scholar : PubMed/NCBI

16 

Molina F, Bouanani M, Pau B and Granier C: Characterization of the type-1 repeat from thyroglobulin, a cysteine-rich module found in proteins from different families. Eur J Biochem. 240:125–133. 1996. View Article : Google Scholar : PubMed/NCBI

17 

Chen TK, Surapaneni AL, Arking DE, Ballantyne CM, Boerwinkle E, Chen J, Coresh J, Köttgen A, Susztak K, Tin A, et al: APOL1 Kidney Risk Variants and Proteomics. Clin J Am Soc Nephrol. 17:684–692. 2022. View Article : Google Scholar : PubMed/NCBI

18 

Kamioka M, Imamura J, Komatsu N, Daibata M and Sugiura T: Testican 3 expression in adult T-cell leukemia. Leuk Res. 33:913–918. 2009. View Article : Google Scholar : PubMed/NCBI

19 

Lou W, Ding B, Zhong G, Du C, Fan W and Fu P: Dysregulation of pseudogene/lncRNA-hsa-miR-363-3p-SPOCK2 pathway fuels stage progression of ovarian cancer. Aging (Albany NY). 11:11416–11439. 2019. View Article : Google Scholar : PubMed/NCBI

20 

Lal CV and Ambalavanan N: Genetic predisposition to bronchopulmonary dysplasia. Semin Perinatol. 39:584–591. 2015. View Article : Google Scholar : PubMed/NCBI

21 

Ye Z, Chen J, Hu X, Yang S, Xuan Z, Lu X and Zhao Q: SPOCK1: A multi-domain proteoglycan at the crossroads of extracellular matrix remodeling and cancer development. Am J Cancer Res. 10:3127–3137. 2020.PubMed/NCBI

22 

Okato A, Arai T, Kojima S, Koshizuka K, Osako Y, Idichi T, Kurozumi A, Goto Y, Kato M, Naya Y, et al: Dual strands of pre-miR-150 (miR-150-5p and miR-150-3p) act as antitumor miRNAs targeting SPOCK1 in naïve and castration-resistant prostate cancer. Int J Oncol. 51:245–256. 2017. View Article : Google Scholar : PubMed/NCBI

23 

Reichard J and Zimmer-Bensch G: The epigenome in neurodevelopmental disorders. Front Neurosci. 15:7768092021. View Article : Google Scholar : PubMed/NCBI

24 

Pimentel-Santos FM, Ligeiro D, Matos M, Mourão AF, Costa J, Santos H, Barcelos A, Godinho F, Pinto P, Cruz M, et al: Whole blood transcriptional profiling in ankylosing spondylitis identifies novel candidate genes that might contribute to the inflammatory and tissue-destructive disease aspects. Arthritis Res Ther. 13:R572011. View Article : Google Scholar : PubMed/NCBI

25 

Vannahme C, Schübel S, Herud M, Gösling S, Hülsmann H, Paulsson M, Hartmann U and Maurer P: Molecular cloning of testican-2: Defining a novel calcium-binding proteoglycan family expressed in brain. J Neurochem. 73:12–20. 1999. View Article : Google Scholar : PubMed/NCBI

26 

Li D, Farrell JJ, Mez J, Martin ER, Bush WS, Ruiz A, Boada M, de Rojas I, Mayeux R, Haines JL, et al: Novel loci for Alzheimer's disease identified by a genome-wide association study in Ashkenazi Jews. Alzheimers Dement. 19:5550–5562. 2023. View Article : Google Scholar : PubMed/NCBI

27 

Yu F, Li G, Gao J, Sun Y, Liu P, Gao H, Li P, Lei T, Chen Y, Cheng Y, et al: SPOCK1 is upregulated in recurrent glioblastoma and contributes to metastasis and Temozolomide resistance. Cell Prolif. 49:195–206. 2016. View Article : Google Scholar : PubMed/NCBI

28 

Xu M, Zhang X, Zhang S, Piao J, Yang Y, Wang X and Lin Z: SPOCK1/SIX1axis promotes breast cancer progression by activating AKT/mTOR signaling. Aging (Albany NY). 13:1032–1050. 2020. View Article : Google Scholar : PubMed/NCBI

29 

Shengxiao X, Xinxin S, Yunxiang Z, Zhijie T and Xiaofei T: Identification of a basement membrane-related gene signature for predicting prognosis, immune infiltration, and drug sensitivity in colorectal cancer. Front Oncol. 14:14281762024. View Article : Google Scholar : PubMed/NCBI

30 

Luo J, Lai C, Xu X, Shi J, Hu J, Guo K, Mulati Y, Xiao Y, Kong D, Liu C and Xu K: Mechanism of prognostic marker SPOCK3 affecting malignant progression of prostate cancer and construction of prognostic model. BMC Cancer. 23:7412023. View Article : Google Scholar : PubMed/NCBI

31 

Ma D, Fetahu IS, Wang M, Fang R, Li J, Liu H, Gramyk T, Iwanicki I, Gu S, Xu W, et al: The fusiform gyrus exhibits an epigenetic signature for Alzheimer's disease. Clin Epigenetics. 12:1292020. View Article : Google Scholar : PubMed/NCBI

32 

Herreros-Pomares A, Llorens C, Soriano B, Bagan L, Moreno A, Calabuig-Fariñas S, Jantus-Lewintre E and Bagan J: Differentially methylated genes in proliferative verrucous leukoplakia reveal potential malignant biomarkers for oral squamous cell carcinoma. Oral Oncol. 116:1051912021. View Article : Google Scholar : PubMed/NCBI

33 

Jensen LD, Hot B, Ramsköld D, Germano RFV, Yokota C, Giatrellis S, Lauschke VM, Hubmacher D, Li MX, Hupe M, et al: Disruption of the Extracellular Matrix Progressively Impairs Central Nervous System Vascular Maturation Downstream of β-Catenin Signaling. Arterioscler Thromb Vasc Biol. 39:1432–1447. 2019. View Article : Google Scholar : PubMed/NCBI

34 

Chai T, Tian M, Yang X, Qiu Z, Lin X and Chen L: Genome-Wide identification of associations of circulating molecules with spontaneous coronary artery dissection and aortic aneurysm and dissection. Front Cardiovasc Med. 9:8749122022. View Article : Google Scholar : PubMed/NCBI

35 

Martinez JR, Dhawan A and Farach-Carson MC: Modular Proteoglycan Perlecan/HSPG2: Mutations, phenotypes, and functions. Genes (Basel). 9:5562018. View Article : Google Scholar : PubMed/NCBI

36 

Gordts PLSM and Esko JD: The heparan sulfate proteoglycan grip on hyperlipidemia and atherosclerosis. Matrix Biol. 71–72. 262–282. 2018.PubMed/NCBI

37 

Pintér A, Hevesi Z, Zahola P, Alpár A and Hanics J: Chondroitin sulfate proteoglycan-5 forms perisynaptic matrix assemblies in the adult rat cortex. Cell Signal. 74:1097102020. View Article : Google Scholar : PubMed/NCBI

38 

Schiffer D, Mellai M, Boldorini R, Bisogno I, Grifoni S, Corona C, Bertero L, Cassoni P, Casalone C and Annovazzi L: The significance of chondroitin sulfate proteoglycan 4 (CSPG4) in human gliomas. Int J Mol Sci. 19:27242018. View Article : Google Scholar : PubMed/NCBI

39 

Swenarchuk LE: Nerve, Muscle, and Synaptogenesis. Cells. 8:14482019. View Article : Google Scholar : PubMed/NCBI

40 

Gridley DS, Mao XW, Tian J, Cao JD, Perez C, Stodieck LS, Ferguson VL, Bateman TA and Pecaut MJ: Genetic and apoptotic changes in lungs of mice flown on the STS-135 mission in space. In vivo. 29:423–433. 2015.PubMed/NCBI

41 

Zhang L, An XP, Liu XR, Fu MZ, Han P, Peng JY, Hou JX, Zhou ZQ, Cao BY and Song YX: Characterization of the transcriptional complexity of the receptive and pre-receptive endometria of dairy goats. Sci Rep. 5:142442015. View Article : Google Scholar : PubMed/NCBI

42 

Hadchouel A, Durrmeyer X, Bouzigon E, Incitti R, Huusko J, Jarreau PH, Lenclen R, Demenais F, Franco-Montoya ML, Layouni I, et al: Identification of SPOCK2 as a susceptibility gene for bronchopulmonary dysplasia. Am J Respir Crit Care Med. 184:1164–1170. 2011. View Article : Google Scholar : PubMed/NCBI

43 

Buga AM, Scholz CJ, Kumar S, Herndon JG, Alexandru D, Cojocaru GR, Dandekar T and Popa-Wagner A: Identification of new therapeutic targets by genome-wide analysis of gene expression in the ipsilateral cortex of aged rats after stroke. PLoS One. 7:e509852012. View Article : Google Scholar : PubMed/NCBI

44 

Weber H, Scholz CJ, Jacob CP, Heupel J, Kittel-Schneider S, Erhardt A, Hempel S, Schmidt B, Kiel T, Gessner A, et al: SPOCK3, a risk gene for adult ADHD and personality disorders. Eur Arch Psychiatry Clin Neurosci. 264:409–421. 2014. View Article : Google Scholar : PubMed/NCBI

45 

Karcher NR, Rogers BP and Woodward ND: Functional connectivity of the striatum in schizophrenia and psychotic bipolar disorder. Biol Psychiatry Cogn Neurosci Neuroimaging. 4:956–965. 2019.PubMed/NCBI

46 

Walker WH II, Walton JC, DeVries AC and Nelson RJ: Circadian rhythm disruption and mental health. Transl Psychiatry. 10:282020. View Article : Google Scholar : PubMed/NCBI

47 

Haukvik UK, Tamnes CK, Soderman E and Agartz I: Neuroimaging hippocampal subfields in schizophrenia and bipolar disorder: A systematic review and meta-analysis. J Psychiatr Res. 104:217–226. 2018. View Article : Google Scholar : PubMed/NCBI

48 

Weissflog L, Scholz CJ, Jacob CP, Nguyen TT, Zamzow K, Gross-Lesch S, Renner TJ, Romanos M, Rujescu D, Walitza S, et al: KCNIP4 as a candidate gene for personality disorders and adult ADHD. Eur Neuropsychopharmacol. 23:436–447. 2013. View Article : Google Scholar : PubMed/NCBI

49 

Bocock JP, Edgell CJ, Marr HS and Erickson AH: Human proteoglycan testican-1 inhibits the lysosomal cysteine protease cathepsin L. Eur J Biochem. 270:4008–4015. 2003. View Article : Google Scholar : PubMed/NCBI

50 

van de Merbel AF, van der Horst G, Buijs JT and van der Pluijm G: Protocols for Migration and Invasion Studies in Prostate Cancer. Methods Mol Biol. 1786:67–79. 2018. View Article : Google Scholar : PubMed/NCBI

51 

Morillo-Bernal J, Fernandez LP and Santisteban P: FOXE1 regulates migration and invasion in thyroid cancer cells and targets ZEB1. Endocr Relat Cancer. 27:137–151. 2020. View Article : Google Scholar : PubMed/NCBI

52 

Pal A, Haliti P, Dharmadhikari B, Qi W and Patra P: Manipulating extracellular matrix organizations and parameters to control local cancer invasion. IEEE/ACM Trans Comput Biol Bioinform. 18:2566–2576. 2021. View Article : Google Scholar : PubMed/NCBI

53 

Quan Q, Wang X, Lu C, Ma W, Han J, Xia G, Yang G and Wang C: Association of extracellular matrix microarchitecture and three-dimensional collective invasion of cancer cells. Biotech Histochem. 95:605–612. 2020. View Article : Google Scholar : PubMed/NCBI

54 

Bakir B, Chiarella AM, Pitarresi JR and Rustgi AK: EMT, MET, plasticity, and tumor metastasis. Trends Cell Biol. 30:764–776. 2020. View Article : Google Scholar : PubMed/NCBI

55 

Pastushenko I and Blanpain C: EMT transition states during tumor progression and metastasis. Trends Cell Biol. 29:212–226. 2019. View Article : Google Scholar : PubMed/NCBI

56 

Ohtsu A: Current status and future prospects of chemotherapy for metastatic gastric cancer: A review. Gastric Cancer. 8:95–102. 2005. View Article : Google Scholar : PubMed/NCBI

57 

Chen D, Zhou H, Liu G, Zhao Y, Cao G and Liu Q: SPOCK1 promotes the invasion and metastasis of gastric cancer through Slug-induced epithelial-mesenchymal transition. J Cell Mol Med. 22:797–807. 2018. View Article : Google Scholar : PubMed/NCBI

58 

Ge R, Wang Z, Montironi R, Jiang Z, Cheng M, Santoni M, Huang K, Massari F, Lu X, Cimadamore A, et al: Epigenetic modulations and lineage plasticity in advanced prostate cancer. Ann Oncol. 31:470–479. 2020. View Article : Google Scholar : PubMed/NCBI

59 

Chen Q, Yao YT, Xu H, Chen YB, Gu M, Cai ZK and Wang Z: SPOCK1 promotes tumor growth and metastasis in human prostate cancer. Drug Des Devel Ther. 10:2311–2321. 2016. View Article : Google Scholar : PubMed/NCBI

60 

Chien MH, Lin YW, Wen YC, Yang YC, Hsiao M, Chang JL, Huang HC and Lee WJ: Targeting the SPOCK1-snail/slug axis-mediated epithelial-to-mesenchymal transition by apigenin contributes to repression of prostate cancer metastasis. J Exp Clin Cancer Res. 38:2462019. View Article : Google Scholar : PubMed/NCBI

61 

Chen ML, Ho CJ, Yeh CM, Chen SL, Sung WW, Wang SC and Chen CJ: High SPOCK1 expression is associated with advanced stage, T value, and gleason grade in prostate cancer. Medicina (Kaunas). 55:3432019. View Article : Google Scholar : PubMed/NCBI

62 

Ma LJ, Wu WJ, Wang YH, Wu TF, Liang PI, Chang IW, He HL and Li CF: SPOCK1 overexpression confers a poor prognosis in urothelial carcinoma. J Cancer. 7:467–476. 2016. View Article : Google Scholar : PubMed/NCBI

63 

Fan LC, Jeng YM, Lu YT and Lien HC: SPOCK1 Is a novel transforming growth factor-β-induced myoepithelial marker that enhances invasion and correlates with poor prognosis in breast cancer. PLoS One. 11:e01629332016. View Article : Google Scholar : PubMed/NCBI

64 

Veenstra VL, Damhofer H, Waasdorp C, Steins A, Kocher HM, Medema JP, ven Laarhoven HW and Bijlsma MF: Stromal SPOCK1 supports invasive pancreatic cancer growth. Mol Oncol. 11:1050–1064. 2017. View Article : Google Scholar : PubMed/NCBI

65 

Roberts DD: Emerging functions of matricellular proteins. Cell Mol Life Sci. 68:3133–3136. 2011. View Article : Google Scholar : PubMed/NCBI

66 

Gerarduzzi C, Hartmann U, Leask A and Drobetsky E: The matrix revolution: Matricellular proteins and restructuring of the cancer microenvironment. Cancer Res. 80:2705–2717. 2020. View Article : Google Scholar : PubMed/NCBI

67 

Yang J, Yang Q, Yu J, Li X, Yu S and Zhang X: SPOCK1 promotes the proliferation, migration and invasion of glioma cells through PI3K/AKT and Wnt/β-catenin signaling pathways. Oncol Rep. 35:3566–3576. 2016. View Article : Google Scholar : PubMed/NCBI

68 

Li Y, Chen L, Chan TH, Liu M, Kong KL, Qiu JL, Li Y, Yuan YF and Guan XY: SPOCK1 is regulated by CHD1L and blocks apoptosis and promotes HCC cell invasiveness and metastasis in mice. Gastroenterology. 144:179–191.e4. 2013. View Article : Google Scholar : PubMed/NCBI

69 

Zhang J, Zhi X, Shi S, Tao R, Chen P, Sun S, Bian L, Xu Z and Ma L: SPOCK1 is up-regulated and promotes tumor growth via the PI3K/AKT signaling pathway in colorectal cancer. Biochem Biophys Res Commun. 482:870–876. 2017. View Article : Google Scholar : PubMed/NCBI

70 

Kong L, Wu Q, Zhao L, Ye J, Li N and Yang H: Identification of messenger and long noncoding RNAs associated with gallbladder cancer via gene expression profile analysis. J Cell Biochem. 120:19377–19387. 2019. View Article : Google Scholar : PubMed/NCBI

71 

Shu YJ, Weng H, Ye YY, Hu YP, Bao RF, Cao Y, Cao Y, Wang XA, Zhang F, Xiang SS, et al: SPOCK1 as a potential cancer prognostic marker promotes the proliferation and metastasis of gallbladder cancer cells by activating the PI3K/AKT pathway. Mol Cancer. 14:122015. View Article : Google Scholar : PubMed/NCBI

72 

Vincent A, Herman J, Schulick R, Hruban RH and Goggins M: Pancreatic cancer. Lancet. 378:607–620. 2011. View Article : Google Scholar : PubMed/NCBI

73 

Ilic M and Ilic I: Epidemiology of pancreatic cancer. World J Gastroenterol. 22:9694–9705. 2016. View Article : Google Scholar : PubMed/NCBI

74 

Li J, Ke J, Fang J and Chen JP: A potential prognostic marker and therapeutic target: SPOCK1 promotes the proliferation, metastasis, and apoptosis of pancreatic ductal adenocarcinoma cells. J Cell Biochem. 121:743–754. 2020. View Article : Google Scholar : PubMed/NCBI

75 

Chen C, Xie L, Ren T, Huang Y, Xu J and Guo W: Immunotherapy for osteosarcoma: Fundamental mechanism, rationale, and recent breakthroughs. Cancer Lett. 500:1–10. 2021. View Article : Google Scholar : PubMed/NCBI

76 

Ritter J and Bielack SS: Osteosarcoma. Ann Oncol. 21 Suppl 7:vii320–vii325. 2010. View Article : Google Scholar : PubMed/NCBI

77 

Li P, Xiao Z, Luo J, Zhang Y and Lin L: MiR-139-5p, miR-940 and miR-193a-5p inhibit the growth of hepatocellular carcinoma by targeting SPOCK1. J Cell Mol Med. 23:2475–2488. 2019. View Article : Google Scholar : PubMed/NCBI

78 

Yu XF, Wang J, OUYang N, Guo S, Sun H, Tong J, Chen T and Li J: The role of miR-130a-3p and SPOCK1 in tobacco exposed bronchial epithelial BEAS-2B transformed cells: Comparison to A549 and H1299 lung cancer cell lines. J Toxicol Environ Health A. 82:862–869. 2019. View Article : Google Scholar : PubMed/NCBI

79 

Xu Y, Zhao P, Xu X, Zhang S, Xia B and Zhu L: T790M mutation sensitizes non-small cell lung cancer cells to radiation via suppressing SPOCK1. Biochem Biophys Rep. 38:1017292024.PubMed/NCBI

80 

Wang T, Liu X, Tian Q, Liang T and Chang P: Reduced SPOCK1 expression inhibits non-small cell lung cancer cell proliferation and migration through Wnt/β-catenin signaling. Eur Rev Med Pharmacol Sci. 22:637–644. 2018.PubMed/NCBI

81 

Koshizuka K, Hanazawa T, Kikkawa N, Katada K, Okato A, Arai T, Idichi T, Osako Y, Okamoto Y and Seki N: Antitumor miR-150-5p and miR-150-3p inhibit cancer cell aggressiveness by targeting SPOCK1 in head and neck squamous cell carcinoma. Auris Nasus Larynx. 45:854–865. 2018. View Article : Google Scholar : PubMed/NCBI

82 

Osako Y, Seki N, Koshizuka K, Okato A, Idichi T, Arai T, Omoto I, Sasaki K, Uchikado Y, Kita Y, et al: Regulation of SPOCK1 by dual strands of pre-miR-150 inhibit cancer cell migration and invasion in esophageal squamous cell carcinoma. J Hum Genet. 62:935–944. 2017. View Article : Google Scholar : PubMed/NCBI

83 

Song X, Han P, Liu J, Wang Y, Li D, He J, Gong J, Li M, Tu W, Yan W, et al: Up-regulation of SPOCK1 induces epithelial-mesenchymal transition and promotes migration and invasion in esophageal squamous cell carcinoma. J Mol Histol. 46:347–356. 2015. View Article : Google Scholar : PubMed/NCBI

84 

Zhu X, Jiang S, Wu Z, Liu T, Zhang W, Wu L, Xu L and Shao M: Long non-coding RNA TTN antisense RNA 1 facilitates hepatocellular carcinoma progression via regulating miR-139-5p/SPOCK1 axis. Bioengineered. 12:578–588. 2021. View Article : Google Scholar : PubMed/NCBI

85 

Verma M, Patel P and Verma M: Biomarkers in prostate cancer epidemiology. Cancers (Basel). 3:3773–3798. 2011. View Article : Google Scholar : PubMed/NCBI

86 

Sambuudash O, Kim HS and Cho MY: Lack of aberrant methylation in an adjacent area of left-sided colorectal cancer. Yonsei Med J. 58:749–755. 2017. View Article : Google Scholar : PubMed/NCBI

87 

Liu G, Ren F and Song Y: Upregulation of SPOCK2 inhibits the invasion and migration of prostate cancer cells by regulating the MT1-MMP/MMP2 pathway. PeerJ. 7:e71632019. View Article : Google Scholar : PubMed/NCBI

88 

Chang AJ, Autio KA, Roach M III and Scher HI: High-risk prostate cancer-classification and therapy. Nat Rev Clin Oncol. 11:308–323. 2014. View Article : Google Scholar : PubMed/NCBI

89 

Ren F, Wang DB, Li T, Chen YH and Li Y: Identification of differentially methylated genes in the malignant transformation of ovarian endometriosis. J Ovarian Res. 7:732014. View Article : Google Scholar : PubMed/NCBI

90 

Taphoorn MJB, Dirven L, Kanner AA, Lavy-Shahaf G, Weinberg U, Taillibert S, Toms SA, Honnorat J, Chen TC, Sroubek J, et al: Influence of treatment with tumor-treating fields on health-related quality of life of patients with newly diagnosed glioblastoma: A secondary analysis of a randomized clinical trial. JAMA Oncol. 4:495–504. 2018. View Article : Google Scholar : PubMed/NCBI

91 

Wessels PH, Weber WE, Raven G, Ramaekers FC, Hopman AH and Twijnstra A: Supratentorial grade II astrocytoma: Biological features and clinical course. Lancet Neurol. 2:395–403. 2003. View Article : Google Scholar : PubMed/NCBI

92 

MacDonald TJ, Pollack IF, Okada H, Bhattacharya S and Lyons-Weiler J: Progression-associated genes in astrocytoma identified by novel microarray gene expression data reanalysis. Methods Mol Biol. 377:203–222. 2007. View Article : Google Scholar : PubMed/NCBI

93 

Ren F, Wang D, Wang Y, Chen P and Guo C: SPOCK2 affects the biological behavior of endometrial cancer cells by regulation of MT1-MMP and MMP2. Reprod Sci. 27:1391–1399. 2020. View Article : Google Scholar : PubMed/NCBI

94 

She S, Yang M, Hu H, Hu P, Yang Y and Ren H: Proteomics based identification of autotaxin as an anti-hepatitis B virus factor and a promoter of hepatoma cell invasion and migration. Cell Physiol Biochem. 45:744–760. 2018. View Article : Google Scholar : PubMed/NCBI

95 

Nakada M, Yamada A, Takino T, Miyamori H, Takahashi T, Yamashita J and Sato H: Suppression of membrane-type 1 matrix metalloproteinase (MMP)-mediated MMP-2 activation and tumor invasion by testican 3 and its splicing variant gene product, N-Tes. Cancer Res. 61:8896–8902. 2001.PubMed/NCBI

96 

Nakada M, Miyamori H, Yamashita J and Sato H: Testican 2 abrogates inhibition of membrane-type matrix metalloproteinases by other testican family proteins. Cancer Res. 63:3364–3369. 2003.PubMed/NCBI

97 

Yu G, Tang Z, Chen H, Chen Z, Wang L, Cao H, Wang G, Xing J, Shen H, Cheng Q, et al: Long-term exposure to 4G smartphone radiofrequency electromagnetic radiation diminished male reproductive potential by directly disrupting Spock3-MMP2-BTB axis in the testes of adult rats. Sci Total Environ. 698:1338602020. View Article : Google Scholar : PubMed/NCBI

98 

Wang LY, Cui JJ, Zhu T, Shao WH, Zhao Y, Wang S, Zhang YP, Wu JC and Zhang L: Biomarkers identified for prostate cancer patients through genome-scale screening. Oncotarget. 8:92055–92063. 2017. View Article : Google Scholar : PubMed/NCBI

99 

Lee SJ, Kim SJ, Seo HH, Shin SP, Kim D, Park CS, Kim KT, Kim YH, Jeong JS and Kim IH: Over-expression of miR-145 enhances the effectiveness of HSVtk gene therapy for malignant glioma. Cancer Lett. 320:72–80. 2012. View Article : Google Scholar : PubMed/NCBI

100 

Du Z, Lin Z, Wang Z, Liu D, Tian D and Xia L: SPOCK1 overexpression induced by platelet-derived growth factor-BB promotes hepatic stellate cell activation and liver fibrosis through the integrin α5β1/PI3K/Akt signaling pathway. Lab Invest. 100:1042–1056. 2020. View Article : Google Scholar : PubMed/NCBI

101 

Morales Johansson H, Newman DR and Sannes PL: Whole-genome analysis of temporal gene expression during early transdifferentiation of human lung alveolar epithelial type 2 cells in vitro. PLoS One. 9:e934132014. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Xiao M, Xue J and Jin E: SPOCK: Master regulator of malignant tumors (Review). Mol Med Rep 30: 231, 2024.
APA
Xiao, M., Xue, J., & Jin, E. (2024). SPOCK: Master regulator of malignant tumors (Review). Molecular Medicine Reports, 30, 231. https://doi.org/10.3892/mmr.2024.13355
MLA
Xiao, M., Xue, J., Jin, E."SPOCK: Master regulator of malignant tumors (Review)". Molecular Medicine Reports 30.6 (2024): 231.
Chicago
Xiao, M., Xue, J., Jin, E."SPOCK: Master regulator of malignant tumors (Review)". Molecular Medicine Reports 30, no. 6 (2024): 231. https://doi.org/10.3892/mmr.2024.13355
Copy and paste a formatted citation
x
Spandidos Publications style
Xiao M, Xue J and Jin E: SPOCK: Master regulator of malignant tumors (Review). Mol Med Rep 30: 231, 2024.
APA
Xiao, M., Xue, J., & Jin, E. (2024). SPOCK: Master regulator of malignant tumors (Review). Molecular Medicine Reports, 30, 231. https://doi.org/10.3892/mmr.2024.13355
MLA
Xiao, M., Xue, J., Jin, E."SPOCK: Master regulator of malignant tumors (Review)". Molecular Medicine Reports 30.6 (2024): 231.
Chicago
Xiao, M., Xue, J., Jin, E."SPOCK: Master regulator of malignant tumors (Review)". Molecular Medicine Reports 30, no. 6 (2024): 231. https://doi.org/10.3892/mmr.2024.13355
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team